(Q37849427)

24 August 2017

1 reference

title

Genetics of Alzheimer's disease: new evidences for an old hypothesis? (English)

1 reference

24 August 2017

0 references

1 reference

24 August 2017

Philippe Amouyel

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21371880

26 November 2024

publication date

1 March 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S0959437X11000451?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

https://api.elsevier.com/content/article/PII:S0959437X11000451?httpAccept=text/plain

26 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Current Opinion in Genetics & Development

26 November 2024

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

295-301

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Amyloid, the presenilins and Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Role of Genes and Environments for Explaining Alzheimer Disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

The Genetics of Human Noninsulin-Dependent (Type 2) Diabetes Mellitus

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Genetic and environmental factors in the cause of Parkinson's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Genetic heterogeneity of Alzheimer's disease: complexity and advances

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

A genome-wide association study for late-onset Alzheimer's disease using DNA pooling

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Genome-wide analysis of genetic loci associated with Alzheimer disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Replication of CLU, CR1, and PICALM associations with alzheimer disease.

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Examination of the current top candidate genes for AD in a genome-wide association study

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Systematic Analysis of Candidate Genes for Alzheimer's Disease in a French, Genome-Wide Association Study

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

The role of apolipoprotein E in Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Contribution of APOE promoter polymorphisms to Alzheimer's disease risk

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Apolipoproteins in human cerebrospinal fluid

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Differential expression of individual complement regulators in the brain and choroid plexus

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes.

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

The choroid plexus in the rise, fall and repair of the brain

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Human monoclonal antibodies against amyloid-beta from healthy adults

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

A new member of the amphiphysin family connecting endocytosis and signal transduction pathways

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Distribution and Expression of Picalm in Alzheimer Disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Where Vascular Meets Neurodegenerative Disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.GDE.2011.02.002

26 November 2024

Identifiers

DOI

1 reference

24 August 2017

1 reference